Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Musculoskeletal Transplant Foundation, Inc.
FDA Inspection
•Musculoskeletal Transplant Foundation, Inc.•November 30, 2012

Musculoskeletal Transplant Foundation, Inc. – FDA Inspection, Nov 30, 2012

Record Details

This FDA Inspection record concerns Musculoskeletal Transplant Foundation, Inc., with an inspection on November 30, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Musculoskeletal Transplant Foundation, Inc.
Inspection Date
November 30, 2012
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · 70d8104e-40d3-43d0-95ec-669d1b542015

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
810372
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies

FDA Citations

15
  1. 21 CFR 1271.320(c)Reportable events not investigated
  2. 21 CFR 1271.320(c)Review and evaluation, report to FDA
  3. 21 CFR 1271.195(c)Monitoring-microorganisms where appropriate
  4. 21 CFR 1271.195(a)(3)Aseptic processing---cleaning, disinfecting
  5. 21 CFR 1271.265(c)(2)Improperly released for distribution
  6. 21 CFR 1271.180(a)Procedures to meet core CTGP
  7. 21 CFR 1271.320(a)Procedures re complaints
  8. 21 CFR 1271.265(e)Procedures and release criteria
  9. 21 CFR 1271.225Verification/validation
  10. 21 CFR 1271.230(a)Validation & approval--established procedures

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Musculoskeletal Transplant Foundation, Inc.

11
DateClassificationOfficeProject area
August 4, 2026Not classifiedNew Jersey District OfficeHuman Cellular, Tissue, and Gene Therapies
June 21, 2024NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 9, 2022NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
November 17, 2021VAICenter for Devices and Radiological HealthPostmarket Assurance: Devices
January 18, 2018VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 11 other inspections on the company page
Other documents for Musculoskeletal Transplant Foundation, Inc.
  • FDA Inspection 1329314 - 2026-08-04
  • FDA Inspection 1229385 - 2024-06-21
  • FDA Inspection 1166490 - 2022-03-09
  • FDA Inspection 1160012 - 2021-11-17
  • FDA Inspection 1038552 - 2018-01-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Musculoskeletal Transplant Foundation, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.